J. Agyin

发表

Effects of a novel proteasome inhibitor BU-32 on multiple myeloma cells

R. Tekmal, N. Kirma, S. Roy, 2014, Cancer Chemotherapy and Pharmacology.

BU-32: a novel proteasome inhibitor for breast cancer

R. Tekmal, H. Nair, S. Roy, 2008, Breast Cancer Research.

Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor.

Xiu-fen Lei, Luzhe Sun, B. Pollock, 2006, Cancer research.

Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis

S. Habib, D. Grzanka, A. P. Terzyk, 2015, Oncotarget.

Steric effects on the C6-C1-C2 valence angle in exo-6-chloronorbornenes: implications for orbital coupling

H. Morrison, John J Nash, J. Agyin, 1999 .

Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells

Luzhe Sun, A. Elkahloun, G. Tomlinson, 2012, Molecular biology of the cell.

Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.

Luzhe Sun, D. Chakravarty, F. Lee, 2010, Cancer research.

Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models

Luzhe Sun, Shu-Chun Lin, I. Yeh, 2010, PloS one.

Award Number: W81XWH-08-1-0604 TITLE: Hormonal Resistance and Metastasis: ER-coregulator-Src Signaling Targeted therapy

Luzhe Sun, F. Lee, S. Nair, 2010 .

Expression, purification and characterization of BG(E)RII: a novel pan-TGFbeta inhibitor.

A. Hinck, Luzhe Sun, Yuping Tang, 2008, Protein engineering, design & selection : PEDS.

Design, synthesis, and biological evaluation of bone-targeted proteasome inhibitors for multiple myeloma.

S. Roy, B. Santhamma, J. Agyin, 2013, Bioorganic & medicinal chemistry letters.